Evidence map›Paper›PMID 22411806›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Rescue of neuronal migration deficits in a mouse model of fetal Minamata disease by increasing neuronal Ca2+ spike frequency.

Jennifer K Fahrion, Yutaro Komuro, Ying Li, Nobuhiko Ohno, Yoav Littner, Emilie Raoult, Ludovic Galas, David Vaudry, Hitoshi Komuro

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Role of Galanin in Cerebellar Granule Cell Migration in the Early Postnatal Mouse during Normal Development and after Injury.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  5. Prenatal Environment That Affects Neuronal Migration.Frontiers in cell and developmental biology · 2019
    Review
  6. Nasal Placode Development, GnRH Neuronal Migration and Kallmann Syndrome.Frontiers in cell and developmental biology · 2019
    Article
  7. Article
  8. Article
  9. Review
  10. Methylmercury and brain development: A review of recent literature.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2016
    Review
  11. Article
  12. Article
  13. Control of cortical neuronal migration by glutamate and GABA.Frontiers in cellular neuroscience · 2015
    Review
  14. Calcium release-dependent actin flow in the leading process mediates axophilic migration.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  15. Role of calcium and mitochondria in MeHg-mediated cytotoxicity.Journal of biomedicine & biotechnology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jennifer K FahrionDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Yutaro Komuro
Ying Li
Nobuhiko Ohno
Yoav Littner
Emilie Raoult
Ludovic Galas
David Vaudry
Hitoshi Komuro
Cleveland Clinic · USInstitute for Research and Innovation in Biomedicine · FRUniversité de Rouen Normandie · FR

Funding

Effects of Methylmercury on Neuronal Cell MigrationR01ES015612 · NIEHS · CLEVELAND CLINIC LERNER COM-CWRU · PI KOMURO, HITOSHI · 2008 to 2010
$951k
NIEHS NIH HHS R01 ES015612NIEHS NIH HHS R01 ES15612
6 · The paper itself

Abstract

In the brains of patients with fetal Minamata disease (FMD), which is caused by exposure to methylmercury (MeHg) during development, many neurons are hypoplastic, ectopic, and disoriented, indicating disrupted migration, maturation, and growth. MeHg affects a myriad of signaling molecules, but little is known about which signals are primary targets for MeHg-induced deficits in neuronal development. In this study, using a mouse model of FMD, we examined how MeHg affects the migration of cerebellar granule cells during early postnatal development. The cerebellum is one of the most susceptible brain regions to MeHg exposure, and profound loss of cerebellar granule cells is detected in the brains of patients with FMD. We show that MeHg inhibits granule cell migration by reducing the frequency of somal Ca(2+) spikes through alterations in Ca(2+), cAMP, and insulin-like growth factor 1 (IGF1) signaling. First, MeHg slows the speed of granule cell migration in a dose-dependent manner, independent of the mode of migration. Second, MeHg reduces the frequency of spontaneous Ca(2+) spikes in granule cell somata in a dose-dependent manner. Third, a unique in vivo live-imaging system for cell migration reveals that reducing the inhibitory effects of MeHg on somal Ca(2+) spike frequency by stimulating internal Ca(2+) release and Ca(2+) influxes, inhibiting cAMP activity, or activating IGF1 receptors ameliorates the inhibitory effects of MeHg on granule cell migration. These results suggest that alteration of Ca(2+) spike frequency and Ca(2+), cAMP, and IGF1 signaling could be potential therapeutic targets for infants with MeHg intoxication.

Indexed as

Calcium SignalingCell MovementAdenineAnimalsAnimals, NewbornCaffeineCalciumCerebellumCyclic AMPDisease Models, AnimalFemaleFetal DiseasesInsulin-Like Growth Factor IMaleMercury Poisoning, Nervous SystemMethylmercury CompoundsAdenineadenosine-3',5'-cyclic phosphorothioateCaffeineCalciumCyclic AMPInsulin-Like Growth Factor IMethylmercury CompoundsThionucleotides

Identifiers

PMID22411806
PMCPMC3323999
OpenAlexW2048027199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.